127 related articles for article (PubMed ID: 37367632)
21. Vestibular Schwannoma Measurements-Is Volumetric Analysis Clinically Necessary?
Selleck AM; Rodriguez JD; Brown KD
Otol Neurotol; 2021 Jul; 42(6):906-911. PubMed ID: 33577243
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Behavior of Asymptomatic Incidental Vestibular Schwannomas Is Similar to That of Symptomatic Tumors.
Carlson ML; Lees KA; Patel NS; Lohse CM; Neff BA; Link MJ; Driscoll CL
Otol Neurotol; 2016 Oct; 37(9):1435-41. PubMed ID: 27576094
[TBL] [Abstract][Full Text] [Related]
23. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
24. Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects.
Slattery WH; Fisher LM; Iqbal Z; Oppenhiemer M
Otol Neurotol; 2004 Sep; 25(5):811-7. PubMed ID: 15354016
[TBL] [Abstract][Full Text] [Related]
25. Growing versus non-growing vestibular schwannomas: assessment of natural history.
Dardis A; Donghun K; Kontorinis G
J Laryngol Otol; 2022 Oct; 136(10):934-938. PubMed ID: 34593068
[TBL] [Abstract][Full Text] [Related]
26. Impact of Aspirin and Other NSAID Use on Volumetric and Linear Growth in Vestibular Schwannoma.
Marinelli JP; Lees KA; Tombers NM; Lohse CM; Carlson ML
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1081-1086. PubMed ID: 30717626
[TBL] [Abstract][Full Text] [Related]
27. Correlation Between Aspirin Intake and Reduced Growth of Human Vestibular Schwannoma: Volumetric Analysis.
Kandathil CK; Cunnane ME; McKenna MJ; Curtin HD; Stankovic KM
Otol Neurotol; 2016 Oct; 37(9):1428-34. PubMed ID: 27631829
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Factors of Hearing Outcome in Untreated Vestibular Schwannomas: Implication of Subdivision of Their Growth by Volumetric Analysis.
Joo JD; Oh SJ; Kim YH; Han JH; Choi BY; Koo JW; Kim CY
World Neurosurg; 2017 Oct; 106():768-774. PubMed ID: 28751138
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II.
Harris GJ; Plotkin SR; Maccollin M; Bhat S; Urban T; Lev MH; Slattery WH
Neurosurgery; 2008 Jun; 62(6):1314-9; discussion 1319-20. PubMed ID: 18824998
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma.
Marston AP; Jacob JT; Carlson ML; Pollock BE; Driscoll CLW; Link MJ
J Neurosurg; 2017 Aug; 127(2):380-387. PubMed ID: 27885952
[TBL] [Abstract][Full Text] [Related]
31. Temporal Dynamics of Pseudoprogression After Gamma Knife Radiosurgery for Vestibular Schwannomas-A Retrospective Volumetric Study.
Breshears JD; Chang J; Molinaro AM; Sneed PK; McDermott MW; Tward A; Theodosopoulos PV
Neurosurgery; 2019 Jan; 84(1):123-131. PubMed ID: 29518221
[TBL] [Abstract][Full Text] [Related]
32. A Subset of Intracanalicular Vestibular Schwannomas Demonstrates Minimal Growth Over a 10-Year Period.
Wu MJ; Knoll RM; Chen JX; Reinshagen K; Roychowdhury P; McKenna MJ; Kozin ED; Remenschneider AK; Jung DH
Otol Neurotol; 2022 Mar; 43(3):376-384. PubMed ID: 35020686
[TBL] [Abstract][Full Text] [Related]
33. Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.
Hunter JB; Francis DO; O'Connell BP; Kabagambe EK; Bennett ML; Wanna GB; Rivas A; Thompson RC; Haynes DS
Otol Neurotol; 2016 Dec; 37(10):1630-1636. PubMed ID: 27668793
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging characteristics and the prediction of outcome of vestibular schwannomas following Gamma Knife radiosurgery.
Wu CC; Guo WY; Chung WY; Wu HM; Lin CJ; Lee CC; Liu KD; Yang HC
J Neurosurg; 2017 Dec; 127(6):1384-1391. PubMed ID: 28186452
[TBL] [Abstract][Full Text] [Related]
35. Tracking Spontaneous Vestibular Schwannoma Regression with Volumetric Measurements.
Patel EJ; Deep NL; Schecht M; Hagiwara M; Roland JT
Laryngoscope; 2021 May; 131(5):E1647-E1652. PubMed ID: 33103767
[TBL] [Abstract][Full Text] [Related]
36. Development of a model to predict vestibular schwannoma growth: An opportunity to introduce new wait and scan strategies.
Hentschel MA; Hannink G; Steens SCA; Mulder JJS; Rovers MM; Kunst HPM
Clin Otolaryngol; 2021 Jan; 46(1):273-283. PubMed ID: 33090707
[TBL] [Abstract][Full Text] [Related]
37. Hearing loss and volumetric growth rate in untreated vestibular schwannoma.
Gurewitz J; Schnurman Z; Nakamura A; Navarro RE; Patel DN; McMenomey SO; Roland JT; Golfinos JG; Kondziolka D
J Neurosurg; 2022 Mar; 136(3):768-775. PubMed ID: 34416729
[TBL] [Abstract][Full Text] [Related]
38. Residual Tumor Volume and Location Predict Progression After Primary Subtotal Resection of Sporadic Vestibular Schwannomas: A Retrospective Volumetric Study.
Breshears JD; Morshed RA; Molinaro AM; McDermott MW; Cheung SW; Theodosopoulos PV
Neurosurgery; 2020 Mar; 86(3):410-416. PubMed ID: 31232426
[TBL] [Abstract][Full Text] [Related]
39. The Influence of Vestibular Schwannoma Tumor Volume and Growth on Hearing Loss.
Patel NS; Huang AE; Dowling EM; Lees KA; Tombers NM; Lohse CM; Marinelli JP; Van Gompel JJ; Neff BA; Driscoll CLW; Link MJ; Carlson ML
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):530-537. PubMed ID: 31986971
[TBL] [Abstract][Full Text] [Related]
40. Retreatment of vestibular schwannoma with Gamma Knife radiosurgery: clinical outcome, tumor control, and review of literature.
Fu VX; Verheul JB; Beute GN; Leenstra S; Kunst HPM; Mulder JJS; Hanssens PEJ
J Neurosurg; 2018 Jul; 129(1):137-145. PubMed ID: 28984523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
